case_images: PMC8202262_01
case_images: Radiologic and medication details of patient 1.. (a) Radiologic details; (b) details of medication history.
case_images: 10.1177_17588359211018028-fig1.jpg
case_images: PMC8202262_01_10.1177_17588359211018028-fig1.jpg
case_images: fig1-17588359211018028
case_images: Chest computed tomography (CT) imaging showed bipulmonal ground-glass opacities (Figure 1). At the time of this case report, the latest positron emission tomography (PET) CT scan showed no evidence for recurrent pneumonitis and showed stable disease (Figure 1).
case_images: PMC8202262_02
case_images: Radiologic and medication details of patient 2.. (a) Radiologic details; (b) details of medication history.
case_images: 10.1177_17588359211018028-fig2.jpg
case_images: PMC8202262_02_10.1177_17588359211018028-fig2.jpg
case_images: fig2-17588359211018028
case_images: The CT scan of the thorax showed basal bipulmonal ground-glass opacities (Figure 2). The prednisolone dose was reduced to 5 mg daily over the course of the treatment, and the follow-up PET scan showed stable disease 3 months after re-exposition (Figure 2).
case_images: PMC8202262_03
case_images: Radiologic and medication details of patient 3.. (a) Radiologic details; (b) details of medication history.
case_images: 10.1177_17588359211018028-fig3.jpg
case_images: PMC8202262_03_10.1177_17588359211018028-fig3.jpg
case_images: fig3-17588359211018028
case_images: Again, thoracic CT scan showed bipulmonal ground-glass opacities (Figure 3).